Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2018-A01731-54 | Other Identifier | ANSM |
Not provided
Not provided
never started
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Anorexia nervosa is an eating disorder whose symptomatology induces a modification of the intestinal microbiota. To date, studies have shown variable profiles without linking them to metabolic and neuropsychological energy phenotyping. This intestinal dysbiosis could be involved in the maintenance of the disorders. Bidirectional communication channels exist between the microbiota, the intestine and the brain. Anomalies in these pathways could explain the impact of the microbiota on the pathophysiology of anorexia nervosa. Therapeutic interventions would then be possible to restore the microbiota in anorexia nervosa and influence the treatment of this disease. This study aims to explore the hypothesis of disruption of the microbiota-intestinal-brain axis transversely and measuring the intestinal microbiota, urinary metabolome, biological factors nutritional, immunological and physiological plasma plasma of the intestine, and finally, the psychological dimensions characteristic of anorexia nervosa.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| restrictive anorexia nervosa with hunger |
| ||
| restrictive anorexia nervosa without hunger |
| ||
| constitutional thinness |
| ||
| control subjects without eating disorders |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| blood sampling | Biological | 12 ml sample |
|
| Measure | Description | Time Frame |
|---|---|---|
| determination of bacterial microbiological profile by 16s sequencing of stool samples | at inclusion |
| Measure | Description | Time Frame |
|---|---|---|
| Determination of the metabolomic profile | evaluated by mass spectrometry (MS/MS) of urine | at inclusion |
| Neurocognitive evaluation | evaluated with questionnaire go-nogo |
Not provided
Inclusion criteria common to all four groups
Inclusion criteria specific to mental anorexia
Inclusion criteria specific to constitutionally thin patients
Inclusion criteria specific to normal weight subjects
Non-inclusion criteria for all subjects :
only female
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Natacha GERMAIN | CHU de Saint Etienne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chu Saint-Etienne | Saint-Etienne | 42055 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000856 | Anorexia Nervosa |
| D001068 | Feeding and Eating Disorders |
| ID | Term |
|---|---|
| D001523 | Mental Disorders |
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
| stool sampling | Other | 20 g sample |
|
| urine sampling | Other | 18 ml sample |
|
| neuropsychological tests | Diagnostic Test |
|
|
| at 2 months |
| Neurocognitive evaluation | evaluated with questionnaire of flexibility | at 2 months |
| Neurocognitive evaluation | evaluated with questionnaire : food troop | at 2 months |
| Neurocognitive evaluation | evaluated with questionnaires : implicit and explicit evaluation. | at 2 months |
| Psychometric scaling for thymic evaluation | evaluated with questionnaire : Child Depression Inventory | at 2 months |
| Psychometric scaling for thymic evaluation | evaluated with questionnaire : Hamilton Depression Rating Scale | at 2 months |
| Determination of the plasma profile of intestinal physiology markers and immunological markers | Intestinal permeability markers: ASCA, antiglycan, anti GP2 IgG/IgA, calprotectin | at inclusion |
| Determination of the plasma profile of intestinal physiology markers and immunological markers | immunoglobulin repertoire: A and M, inflammatory molecules: C-reactive protein | at inclusion |
| Determination of the plasma profile of intestinal physiology markers and immunological markers | circulating interleukins of the Th17 profile: IL17, IL23, IL6, IL1β, IL 22, IL21, IL33, IL31, TNFα, IFNγ, IL9, IL10, IL4. | at inclusion |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |